A new online journal club, RheumJC, launches with two live chats on Twitter on January 29. It's the first journal club ever in rheumatology, an opportunity for rheumatologists worldwide to discuss important published research.
In court decision to approve generic colchicine for gout, American College of Rheumatology arguments about the risk to patients of exorbitant pricing may have played an important role. Is this a harbinger of something?
Pregnancy outcomes for women taking medications for rheumatic disease offer reassuring information. Also, details about forthcoming labeling changes for medications used during pregnancy, including biologics.
Positioning of the probe is "three-quarters of the battle" in diagnosing synovitis of the wrist or hand, says Dr. DeMarco in this video. But gel technique and pressure are crucial to gaining accurate clinical information from ultrasound imaging of this condition.
(ACR14) (VIDEO) In tests so far, the infliximab biosimilar BOW015, just approved in India, seems to look about the same to the human immune system as the original. Here, a VP of the company behind BOW015 talks about the realities of seeking approval in the US.
(ACR2014) (VIDEO) The National Institutes of Health's PROMIS measures, created to study health status in the general population, look good for meaningful outcomes assessment in diseases such as rheumatoid arthritis, says an expert who studies measurement of disability in rheumatic disorders..
(VIDEO) First, a live demonstration of ultrasound probe placement to examine the Achilles tendon for enthesitis. Then, a narrated series of still slides and films showing normal and abnormal views from the ultrasound monitor.
(ACR Pediatrics 2014) How will the hundreds of new genetic biomarkers being found in rheumatology help us to untangle the web of complex diseases? In a brief podcast, a specialist in both rheumatology and genetics discusses recent and future progress.